IE41628L - Erythromycin pyroglutamate - Google Patents
Erythromycin pyroglutamateInfo
- Publication number
- IE41628L IE41628L IE147275A IE147275A IE41628L IE 41628 L IE41628 L IE 41628L IE 147275 A IE147275 A IE 147275A IE 147275 A IE147275 A IE 147275A IE 41628 L IE41628 L IE 41628L
- Authority
- IE
- Ireland
- Prior art keywords
- erythromycin
- pyroglutamate
- july
- gb1485210a
- perlingually
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 7
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 title abstract 3
- 229960003276 erythromycin Drugs 0.000 title abstract 3
- 229940043131 pyroglutamate Drugs 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000003385 bacteriostatic effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical class CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1485210 Compositions containing erythromycin pyroglutamate ROUSSEL-UCLAF 2 July 1975 [2 July 1974] 27809/75 Heading A5B [Also in Division C2] Pharmaceutical compositions having bacteriostatic and bactericidal activity comprise, as active ingredient, erythromycin pyroglutamate, in association with a suitable pharmaceutical vehicle and optionally other active ingredients such as erythromycin base and a colistin salt, e.g. the sulphate. They may be administered orally, perlingually, topically or transcutaneously in the form of tablets, capsules, injectable solutions or suspensions, creams or ointments.
[GB1485210A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7423013A FR2302084A1 (en) | 1974-07-02 | 1974-07-02 | NEW ERYTHROMYCIN SALT, ITS PREPARATION PROCESS AND ITS APPLICATION AS A MEDICINAL PRODUCT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE41628L true IE41628L (en) | 1976-01-02 |
| IE41628B1 IE41628B1 (en) | 1980-02-13 |
Family
ID=9140790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE147275A IE41628B1 (en) | 1974-07-02 | 1975-07-02 | New erythromycin salt process for preparing it and compositions incorporating it |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5129217A (en) |
| BE (1) | BE830842A (en) |
| CA (1) | CA1025442A (en) |
| CH (1) | CH599152A5 (en) |
| DE (1) | DE2529538A1 (en) |
| DK (1) | DK299375A (en) |
| FR (1) | FR2302084A1 (en) |
| GB (1) | GB1485210A (en) |
| IE (1) | IE41628B1 (en) |
| LU (1) | LU72866A1 (en) |
| NL (1) | NL7507863A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5633353A (en) * | 1979-08-20 | 1981-04-03 | Toray Ind Inc | Reeling-out method for thread |
| JP3345652B2 (en) * | 1994-06-29 | 2002-11-18 | 明治製菓株式会社 | Stabilized composition comprising colistin sulfate |
-
1974
- 1974-07-02 FR FR7423013A patent/FR2302084A1/en active Granted
-
1975
- 1975-06-30 LU LU72866A patent/LU72866A1/xx unknown
- 1975-06-30 CA CA230,434A patent/CA1025442A/en not_active Expired
- 1975-06-30 BE BE157851A patent/BE830842A/en not_active IP Right Cessation
- 1975-07-01 CH CH856875A patent/CH599152A5/xx not_active IP Right Cessation
- 1975-07-01 JP JP8055475A patent/JPS5129217A/en active Pending
- 1975-07-02 IE IE147275A patent/IE41628B1/en unknown
- 1975-07-02 NL NL7507863A patent/NL7507863A/en not_active Application Discontinuation
- 1975-07-02 GB GB2780975A patent/GB1485210A/en not_active Expired
- 1975-07-02 DK DK299375A patent/DK299375A/en unknown
- 1975-07-02 DE DE19752529538 patent/DE2529538A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IE41628B1 (en) | 1980-02-13 |
| DE2529538A1 (en) | 1976-01-22 |
| LU72866A1 (en) | 1976-04-13 |
| NL7507863A (en) | 1976-01-06 |
| BE830842A (en) | 1975-12-30 |
| CH599152A5 (en) | 1978-05-12 |
| DK299375A (en) | 1976-01-03 |
| FR2302084A1 (en) | 1976-09-24 |
| GB1485210A (en) | 1977-09-08 |
| CA1025442A (en) | 1978-01-31 |
| FR2302084B1 (en) | 1979-05-18 |
| JPS5129217A (en) | 1976-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2033725A1 (en) | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid | |
| EP0208519A3 (en) | Solubilized composition of hardly-soluble pharmaceutical product | |
| GB1458251A (en) | 1-phenyl-2-amino-ethanol derivatives | |
| GB1485210A (en) | Erythromycin salt processes for preparing it and compositions incorporating it | |
| GB1425150A (en) | Therapeutically active phenoxyalkylamines | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| AU476979B2 (en) | 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof | |
| GB1252286A (en) | ||
| GB1275607A (en) | Pharmaceutical compositions | |
| GB1256723A (en) | ||
| IE35507B1 (en) | Anti-inflammatory preparations containing tetrahydrocarbazole derivatives | |
| IE34386B1 (en) | Pharmaceutical compositions | |
| IE39587B1 (en) | Antibacterial compositions | |
| GB1451389A (en) | Indolobenzazepines | |
| CA1026678A (en) | Solubilized acetylsalicylic acid composition | |
| AU476756B2 (en) | PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID | |
| IE38940B1 (en) | Pharmaceutical compositions containing p-chlorohippuric acid or salts thereof | |
| GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
| IE35047L (en) | Benzazepine derivatives. | |
| IE39264L (en) | Pharmaceutical preparations. | |
| GB1321466A (en) | N-acetyl-6-amino-hexanoic acid derivative process for its production and pharmaceutical compositions containing the derivative | |
| GB1397675A (en) | Proline compounds | |
| IE37186B1 (en) | Improvements in and relating to the production of benzyl-pyrimidines | |
| GB1193438A (en) | Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them | |
| GB1264197A (en) |